Efficacy and Safety of Pitavastatin in Children and Adolescents at High Future Cardiovascular Risk

Objectives To assess the safety and efficacy of pitavastatin in children and adolescents with hyperlipidemia. Study design A total of 106 children and adolescents with hyperlipidemia, ages 6 to 17 years, were enrolled in a 12-week randomized, double-blind, placebo-controlled study and randomly assig...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of pediatrics 2015-08, Vol.167 (2), p.338-343.e5
Hauptverfasser:	Braamskamp, Marjet J.A.M., MD, Stefanutti, Claudia, MD, PhD, Langslet, Gisle, MD, Drogari, Euridiki, MD, PhD, Wiegman, Albert, MD, PhD, Hounslow, Neil, MRCP, FFPM, Kastelein, John J.P., MD, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Age Factors Apolipoproteins - blood Cardiovascular Diseases - blood Cardiovascular Diseases - etiology Child Cholesterol - blood Dose-Response Relationship, Drug Double-Blind Method Europe Female Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hyperlipidemias - blood Hyperlipidemias - drug therapy Male Pediatrics Quinolines - pharmacokinetics Quinolines - therapeutic use Risk Factors Treatment Outcome Triglycerides - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!